Laboratory Products
Cryopreservation Excipient for Cell Therapies: Maximise Cell Viability and Recovery
Sep 21 2021
The importance of reliable and safe cell cryopreservation
Rapid developments in cell, tissue, and gene therapies over the last decade have redefined what a cell therapy can be. The use of living cells as the active medicinal ingredient present great opportunities to deliver treatment that can trigger the body’s own capacity to regenerate damaged or diseased tissue. However, the development of a cell therapy using a process that includes the washing out of the cryopreservation solution is not only inconvenient but can result in loss of cells and lower cell viability.
Unique formulation achieves high cell viability even after long-term cryopreservation
AMSBIO has launched STEM-CELLBANKER® EX, a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development.
Assisting easier implementation in a clinical environment, STEM-CELLBANKER® EX is a chemically defined cryopreservation media solution that only includes components registered as inactive ingredients that have already been approved for intravenous administration. Manufactured under strict US, EU and PIC/S GMP guidelines, STEM-CELLBANKER® EX is a serum free and animal component free, sterile DMSO-containing solution optimised for cryopreserving human cells, tissues and organoids.
Proven to maintain cell pluripotency, normal karyotype, and proliferation ability post-thaw - STEM-CELLBANKER® EX delivers consistently higher cell viability and cell recovery than other cryopreservation media.
More information online
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan